Center-Authored Papers

Filters: Author is Baeten, Jared M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2009
Piantadosi A, Chohan B, Panteleeff D, Baeten JM, Mandaliya K, Ndinya-Achola JO, Overbaugh J.  2009.  HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response.. AIDS (London, England). 23(5):579-87. Abstract
Piantadosi A, Panteleeff D, Blish CA, Baeten JM, Jaoko W, McClelland SR, Overbaugh J.  2009.  Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.. Journal of virology. 83(19):10269-74. Abstract
2010
Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, Delany-Moretlwe S, Baeten JM, Hughes JP, Wald A et al..  2010.  Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women.. Journal of acquired immune deficiency syndromes (1999). 53(5):606-13. Abstract
Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, Mugo N, Bukusi EA, Cohen CR, Katabira E et al..  2010.  Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.. Lancet. 375(9717):824-33. Abstract
Curlin ME, Huang M-L, Lu X, Celum CL, Sanchez J, Selke S, Baeten JM, Zuckerman RA, Erdman DD, Corey L.  2010.  Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men.. PloS one. 5(6):e11321. Abstract
Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, Stevens WS, Donnell D, Campbell MS, Farquhar C et al..  2010.  Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.. PloS one. 5(9):e12598. Abstract
Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C.  2010.  Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.. Lancet. 375(9731):2092-8. Abstract
Baeten JM, Donnell D, Kapiga SH, Ronald A, John-Stewart G, Inambao M, Manongi R, Vwalika B, Celum C.  2010.  Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples.. AIDS (London, England). 24(5):737-44. Abstract
2011
Campbell MS, Mullins JI, Hughes JP, Celum C, Wong KG, Raugi DN, Sorensen S, Stoddard JN, Zhao H, Deng W et al..  2011.  Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.. PloS one. 6(3):e16986. Abstract
Mugo NR, Med M, Heffron R, Donnell D, Wald A, Were EO, Rees H, Celum C, Kiarie JN, Cohen CR et al..  2011.  Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1 serodiscordant couples.. AIDS (London, England). 25(15):1887-1895. Abstract
Mujugira A, Baeten JM, Donnell D, Ndase P, Mugo NR, Barnes L, Campbell JD, Wangisi J, Tappero JW, Bukusi E et al..  2011.  Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.. PloS one. 6(10):e25828. Abstract
Lingappa JR, Petrovski S, Kahle E, Fellay J, Shianna K, McElrath MJ, Thomas KK, Baeten JM, Celum C, Wald A et al..  2011.  Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.. PloS one. 6(12):e28632. Abstract
Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Wald A, Corey L, Donnell D et al..  2011.  Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission.. Science translational medicine. 3(77):77ra29. Abstract
Baeten JM, Lingappa J, Beck I, Frenkel LM, Pepper G, Celum C, Wald A, Fife KH, Were E, Mugo N et al..  2011.  Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.. The Journal of infectious diseases. 203(1):117-21. Abstract
Hallett TB, Baeten JM, Heffron R, Barnabas R, de Bruyn G, Cremin Í, Delany S, Garnett GP, Gray G, Johnson L et al..  2011.  Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.. PLoS medicine. 8(11):e1001123. Abstract
Jacob ST, Baeten JM, Hughes JP, Peinado J, Wang J, Sanchez J, Reid SE, Delany-Moretlwe S, Cowan F, Fuchs JD et al..  2011.  A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial.. AIDS and behavior. 15(5):897-904. Abstract
2012
Murnane PM, Hughes JP, Celum C, Lingappa JR, Mugo N, Farquhar C, Kiarie J, Wald A, Baeten JM.  2012.  Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission.. PloS one. 7(11):e51192. Abstract
Hughes JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, de Bruyn G, Kiarie J, Inambao M, Kilembe W, Farquhar C et al..  2012.  Determinants of Per-Coital-Act HIV-1 Infectivity Among African HIV-1-Serodiscordant Couples.. The Journal of infectious diseases. 205(3):358-365. Abstract
Mackelprang RD, Baeten JM, Donnell D, Celum C, Farquhar C, de Bruyn G, Essex M, McElrath MJ, Nakku-Joloba E, Lingappa JR.  2012.  Quantifying Ongoing HIV-1 Exposure in HIV-1-Serodiscordant Couples to Identify Individuals With Potential Host Resistance to HIV-1.. The Journal of infectious diseases. 206(8):1299-1308. Abstract
Ndase P, Celum C, Thomas K, Donnell D, Fife KH, Bukusi E, Delany-Moretlwe S, Baeten JM.  2012.  Outside Sexual Partnerships and Risk of HIV Acquisition for HIV Uninfected Partners in African HIV Serodiscordant Partnerships.. Journal of acquired immune deficiency syndromes. 59(1):65-71. Abstract
Blish CA, McClelland SR, Richardson BA, Jaoko W, Mandaliya K, Baeten JM, Overbaugh J.  2012.  Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.. Journal of acquired immune deficiency syndromes (1999). 61(4):436-40. Abstract
Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J et al..  2012.  Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.. The Lancet infectious diseases. 12(1):19-26. Abstract
Lu Y, Celum C, Wald A, Baeten JM, Cowan F, Delany-Moretlwe S, Reid SE, Hughes JP, Wilcox E, Corey L et al..  2012.  Acyclovir achieves lower concentration in African HIV-seronegative, HSV-2 seropositive women compared to non-African populations.. Antimicrobial agents and chemotherapy. 56(5):2777-9. Abstract
Baeten JM, Reid SE, Delany-Moretlwe S, Hughes JP, Wang RS, Wilcox E, Limbada M, Akpomiemie G, Corey L, Wald A et al..  2012.  Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial.. Sexually transmitted diseases. 39(1):21-4. Abstract
Jacob ST, Banura P, Baeten JM, Moore CC, Meya D, Nakiyingi L, Burke R, Horton CL, Iga B, Wald A et al..  2012.  The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: A prospective intervention study.. Critical care medicine. 40(7):2050-8. Abstract